We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sovgem | SOV | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 16.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 16.00 |
| Top Posts |
|---|
Posted at 22/5/2008 15:56 by malinkie Big question mark over management. Pedalling this one trip to China 2-3 years ago and dont seem to come up with much new. Sitting over in the Channel Isles looking at the sea wont get investors decent returns, need to be out and about really investigating potential companies. Bargepole job! |
Posted at 16/5/2007 15:25 by jonwig markralph - sorry, I don't hold this any more, having made a bit from 11p (on the way down), 9p, 7p and out around 17p last year.They are shrewd investors, though (look how they exited from Bodisen in good time!) and should do well for you. Best of luck. |
Posted at 11/10/2006 18:23 by jonwig Interesting posts while I've had a couple of days away - thanks guys.Fundraising - ITs (and SOV is one, in effect if not in law) really have to raise new money at NAV, otherwise either new or old investors are disadvantaged. This doesn't arise if the shares are trading at a premium to NAV. Now I know they IPO-ed at 50p with NAV of 12.5p - I suppose that will remain one of life's big mysteries. John (post #318) - small explo miners are trading at pretty low levels and any IT investing in them (such as Starvest) will probably suffer the same fate, and then some more. Also, (post #320) KIM was a surprise investment to me: China...? It was one of the reasons I sold my last lot. |
Posted at 03/3/2006 12:23 by jonwig Article in today's IC; part of a feature on playing Asian markets. Here it is:SovGEM is yet another interesting small investment company in the mould of London Asia. Unlike its peers CYC and EnterpriseAsia, SovGEM has come up with a clever strategy that appears to be paying off. Basically, SovGEM is a way of buying into small, quoted Chinese and Russian stocks on the New York over-the-counter market and the UK-based Ofex market. A quick wiz through its investments reveals a number of clever buys. - Bodisen Biotech, an eco-friendly, bio-fertiliser company that's traded on the US markets for a few years and has just listed in the UK. SovGEM bought $1m-worth of shares for $4.50 - they're now worth $14.92 a share. - Harbin Electric, which makes something called linear induction motors. These shares were bought at $2, yet they now trade at $8.25. - American Oriental Bioengineering. Bought at $4.80, but now trading at $5.40. - China Natural Gas. Bought at $2.80, but now trading at $5. - Concorde Oil and Gas, a Russian oil minnow quoted on Ofex. SovGEM has also invested £500,000 for a 1.5 per cent stake in the Tynda forest, in the Amur region of the Russian Far East. Fellow investors include Peter Hambro from Peter Hambro Mining. What's the sector play? Small resources and biotech over-the-counter stocks in the UK and the US. What's the risk? That wide spread of quoted investments could crash if stock markets suddenly fall. What's the potential reward? A share price level with net asset value of 25p looks reasonable. Verdict: SovGEM appears to represent good value and is worth a small punt if you want access to a wide range of racy, primarily US-quoted, micro small caps. |
Posted at 05/2/2006 11:27 by jonwig Bodisen starts trading on Monday 6 Feb. This is Growth Company Investor's view: Chinese fertiliser maker Bodisen Biotech starts trading on AIM on Monday after a £12 million placing. Broker Charles Stanley arranged the placing for Bodisen, which is already listed on the American Stock Exchange, where the shares have recently traded at $18 substantially above the $13 (£8) price at which the oversubscribed AIM placing was carried out.* At the American price, the company boasts a market value of $279 million. 'This is the first company to obtain a dual listing on AMEX and AIM,' says Richard Thompson of Charles Stanley, who has been working on the complicated transaction for almost a year. 'We needed to obtain SEC registration in the US,' he explained. Bodisen, which makes organic fertiliser in both liquid and compound forms, is also the biggest Chinese business yet to float on AIM, joining such ventures as orange grower Asian Citrus. Bodisen has seen revenues more than treble since 2002 and Charles Stanley predicts net profits of $5 million for 2005 on turnover up 76 per cent to $28.6 million. The money raised will fund the construction of two new factories in China to expand the company's distribution range. Founders and executive directors Qiong Wang and Bo Chen will see their 47.4 per cent stake diluted by almost ten per cent. A range of UK institutions supported the AIM flotation, alongside pre-IPO investor SovGem, which itself is listed on AIM. Yesterday SovGem issued a trading update, revealing a net asset value of 24.5p a share, against a recent share price of 15p. SovGem has also backed five other Chinese or Russian ventures, including OFEX-traded Concorde Oil & Gas, which has nearly quadrupled in value. Concorde plans to join AIM shortly. Another intriguing concern is Russian timber producer Tynda Forest, which also hopes to join AIM this year. The company operates just over the border from China in the far east of Russia and supplies markets nearby. Tynda boasts mining specialist Peter Hambro as chairman. His son Leo is managing director. Expect some lively trading on Monday. *May explain share price drop on Friday? |
Posted at 26/1/2006 09:31 by milner2 CHNG 5.25p heres why.Bodisen Biotech Announces 8.6% Equity Stake in China Natural Gas, Inc. (Stock Symbol: CHNG). Wednesday January 25, 8:00 am ET NEW YORK--(BUSINESS WIRE)--Jan. 25, 2006--Bodisen Biotech, Inc., (AMEX:BBC, website: www.bodisen.com), the first China based environmentally friendly bio fertilizer company listed on a U.S. stock exchange, announced today that one of Bodisen's strategic investment projects, China based Xi Lan Natural Gas Co. Ltd, recently became a public company in the U.S. under the name of China Natural Gas, Inc., (OTCBB: CHNG - News, www.naturalgaschina. Bodisen owns 2,063,768 shares of CHNG, representing approximately 8.6% of CHNG which it purchased in October 2005 for approximately $2.85 million. One of the key components of Bodisen's compound fertilizer products is urea, which is manufactured through natural gas. Ms. Karen Qiong Wang, Chairman & CEO of Bodisen commented, "This strategic investment allows Bodisen to potentially benefit from lower raw material costs as China Natural Gas becomes a supplier of natural gas to some of the largest urea manufacturers in the Shaanxi province. Bodisen is confident that the China Natural Gas management team has the experience needed to continue to grow its highly profitable business. China Natural Gas' recent completion of $10.4 million in financing with institutional investors is a testament to the strength and scalability of its business model and its potential as a public company in the U.S. capital markets. Bodisen is pleased to own a significant equity stake in one of China's best run natural gas services providers." Mr. Minqing Lu, CEO of China Natural Gas commented, "Having completed our recent equity financing with a syndicate that has U.S. and international institutional investor reach, we are now able to move forward with our investment in the construction and acquisition of retail compressed natural gas filling stations in the Xian marketplace. Through our partnership with Bodisen, we will both be able to grow together in China while still maintaining each company's individual focus on producing solid results to enhance shareholder value for our investors." About Bodisen Biotech, Inc. A Delaware company, Bodisen is headquartered in Shaanxi, China's agricultural hub. The Bodisen brand is a highly recognized fertilizer brand in China. Its environmentally friendly "green" products support the mandate of the Chinese government to increase crop yields for the purpose of decreasing China's dependency on food imports. Among China's population of 1.3 billion, approximately 900 million are farmers whose incomes depend on their crop yields. With over 60 products and approximately 600 (and growing) nationwide distribution centers, Bodisen has experienced rapid growth. Bodisen's products are based on proprietary agricultural technology jointly developed by company scientists and university laboratories. These products address grains, vegetables, and fruit crops and have been proven to increase crop yields by 10% to 35% while being 100% environmentally friendly. In early January 2006, Forbes Magazine ranked Bodisen Biotech among the "Top 20 Growth Companies in China." About China Natural Gas, Inc. China Natural Gas, Inc., ("CHNG"), a Delaware company, is the first China based US public natural gas services provider that owns and operates a 120 kilometer long compressed natural gas pipeline in China's Xi'An area, a fast growing Chinese city supported by a population of 7 million and is the "gateway" to the broad Western regions of China. CHNG has three profitable business segments: end user delivery of natural gas services to residential and industrial customers, wholesale natural gas to retail natural gas filling stations, and retail natural gas at company owned natural gas filling stations. The city of Xi'An has approximately 20,000 Taxis, 3,000 buses and 2,000 special purpose vehicles that are powered by compressed natural gas. Safe Harbor Statement This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Contact: Investor Relations: The Piacente Group, Inc. Debra Chen, 212-481-1907 debra@thepiacentegro -------------------- Source: Bodisen Biotech, Inc. |
Posted at 24/1/2006 10:28 by coroon Thats strange,I made my purchase at 08.54 its taken an hour to show on the iii trades,and it's recorded as a sell.Could possibly mislead future investors. |
Posted at 11/1/2006 15:51 by nappers Getting a nice pop today - I do not think this is the CON investment today. More likely value investors coming in to narrow the NAV discount in what could be a hot sector this year - 100k T trade yesterday and maybe the same today. AOB also looks like it could be on a good bull run to new highs if the last few days continues..BOD also continues higher... |
Posted at 08/1/2006 07:37 by jonwig From the Telegraph:Chinese fertiliser group targets Aim By Edward Simpkins (Filed: 08/01/2006) A Chinese company that manufactures agricultural fertilisers is planning to list on London's Alternative Investment Market within the next few weeks with a value of more than £100m. Bodisen Biotech, which was named by Forbes Magazine as one of the 100 fastest growing companies in China, expects to raise about £10m from investors in London and Hong Kong when it comes to Aim. A pity we haven't many of these left: I imagine it will be a strong debut. |
Posted at 27/12/2005 09:40 by jonwig Hi coroon, good to see you back.First reaction is that the increase will slow growth, assuming they don't want to start an inflationary cycle. Slower growth would be no bad thing for their economy! Provided they can manage the 're-entry'. As far as SOV goes, next year could be very productive. Their stated policy is and has been to realise profits, which they've done successfully this year, and the Tynda Forest stake could well be realised (at least in part) if it floats on AIM next year. Look at the increase of nearly 50% in NAV in about a year, and remember that their pile of cash will have been a drag on that. It's only the share price which has lagged, but with a few new investors on board, including hedge funds, the bet is that this will change. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
